The drug is used for hormone replacement therapy (HRT). It contains two different female sex hormones: estrogen (estradiol) and progestin (dydrogesterone). It is used in postmenopausal women whose last menstrual period (menopause) was at least 12 months ago.
The medicine is used for
Relief of postmenopausal symptoms
During menopause, a woman’s production of her own estrogen decreases. This can cause symptoms such as hot flashes in the face, neck, and chest (called hot flashes). The drug relieves these symptoms that occur after menopause. You will only be prescribed medication if your symptoms significantly affect your daily life.
The medicine cannot be taken
if the following points apply to you. If you are unsure whether this is the case, consult your doctor before taking the product.
You should not take the medicine if:
You have a hypersensitivity (allergy) to estradiol, dydrogesterone, or any other ingredient of this medicine.
You have, have had, or are suspected of having breast cancer.
You have a form of cancer that depends on estrogen to grow, for example. B. Cancer of the uterine mucosa (endometrium) or there is appropriate suspicion.
Bleeding from the vagina occurs, the cause of which is not clear.
Untreated excessive thickening of the lining of the uterus (endometrial hyperplasia).
You have or have previously had a blood clot in a vein (thrombosis), for example. B. in the legs (deep vein thrombosis) or in the lungs (pulmonary embolism)
You have a bleeding disorder (such as protein C deficiency, protein S deficiency, or antithrombin deficiency)
You have or have ever had a condition caused by blood clots in your arteries, such as: B. Heart attack, stroke, or attacks of chest pain with a feeling of tightness in the chest (angina)
You have or have ever had liver disease and your liver function tests have not yet returned to normal.
You have a rare inherited blood disorder called porphyria.
You have a hypersensitivity (allergy) to estradiol, dydrogesterone, or any other ingredient of this medicine.
If any of the above diseases occur for the first time while taking the drug, immediately stop treatment and consult a doctor immediately.
Always take this medication exactly as your doctor has told you. If you are unsure, consult your doctor or pharmacist.
Start of reception
Start taking it only if at least 12 months have passed since your last natural menstrual period.
You can start taking it at any time
You are not currently taking hormone replacement therapy.
You are switching from continuous combined hormone replacement therapy.
This is the case if you take/use a pill or patch with two active ingredients, estrogen and progestin, every day.
You will start taking it after completing your 28 day cycle if
You are switching from a cyclic or sequential product to this product. This is the case if you take an estrogen-only pill or patch in the first half of your cycle. Then take a pill or patch with two active ingredients, estrogen and progestin, for the next 14 days.
dosage
Your doctor will try to give you the minimum dose needed to treat your symptoms for the shortest time possible. Please talk to your doctor if you feel that the effect of the medicine is too strong or too weak.
Take one yellow tablet daily for 28 days.
If you are scheduled for surgery
If you are scheduled for surgery, tell the doctor performing the surgery that you are taking this drug. You may need to stop taking the medicine 4 to 6 weeks before your scheduled surgery to reduce the risk of blood clots. Ask your doctor when you can continue taking it.
If you took more than you should
If you (or someone else) takes too many pills, it is unlikely to cause serious problems. You may feel sick (nausea) or sick (vomiting), and you may also experience chest pain/tenderness, dizziness, stomach cramps, drowsiness, fatigue, or withdrawal bleeding. No specific treatment is required. However, if you are concerned, please consult your doctor.
If you forget to take it
Take the missed film-coated tablet as soon as possible. However, if more than 12 hours have passed since your usual dose, continue with the next dose without taking the missed film-coated tablet. Do not take a double dose. If you forget to take a dose, you may experience bleeding or spotting.
If you stop taking it
You should not stop treatment without consulting your doctor.
If you have any more questions about taking this medicine, talk to your doctor or pharmacist.
View cart “Эвиста, Evista, 60mg, 84” has been added to your cart.
View cart “Эвиста, Evista, 60mg, 84” has been added to your cart.
Femoston mini 0.5 mg/2.5 mg Filmtabletten 84 Stk. (Estradiol 0,5 mg / Dydrogesteron 2,5 mg)
€74.82
The medicine is used to relieve postmenopausal symptoms.
Description
Additional information
Shipping & Delivery
Related products
Utrogestan Luteal 200mg Weichkap.z.vaginal.Anwend. 90 Stk.(Progesterone)
€177.32
Fosamax, 70mg, 12
€108.72
What is Fosamax?
The drug Fosamax (alendronic acid) belongs to a group of medicines called bisphosphonates. This drug changes the cycle of formation and breakdown of bone tissue in the body.
Among the main indications for the use of Fosamax tablets is osteoporosis in women after the onset of menopause and in the postmenopausal period, which helps prevent serious pathological conditions such as fractures of the femoral neck, vertebrae, wrist bones and hands. Osteoporosis after menopause is associated with a decrease in estrogen levels, which prevents bone thinning and improves bone quality. As a result of a decrease in this hormone, bone resorption increases, which leads to a decrease in bone mineral density, bones become weakened and more prone to fracture. You can buy Fosamax in our online pharmacy. It is used by women to treat and prevent osteoporosis associated with menopause.
This drug is also commonly used in men to treat osteoporosis caused by steroid use.
Other indications for the use of Fosamax (alendronic acid) include:
Paget's disease (osteitis deformans, osteodystrophy) in women and men
Prevention of osteoporosis (caused by the use of glucocorticoids)
Treatment of osteoporosis in men and women
During treatment with Fosamax, normal bone tissue is formed. In therapeutic doses, alendronic acid does not cause osteomalacia. This drug has proven itself in the treatment of postmenopausal osteoporosis in women due to a significant increase in bone density. Therefore, reviews and reviews of Fosamaka are positive. Data from clinical studies demonstrate the high efficacy of the drug. Read the package insert for Fosamax before starting treatment.